Apexigen Company
Apexigen is a biopharmaceutical product development company developing products to address life-threatening and difficult to treat diseases.
Total Funding:
$158M
Investor Type:
N/A
Technology:
Data-driven Technologies
Investment Stage:
N/A
Last Funding Type:
Series C
Estimated Revenue:
$1M to $10M
Founded Date:
2010
Industry:
PharmTech
Employee Number:
11-50
Funding Status:
Late Stage Venture
Number Of Exists:
N/A
Headquarters:
Burlingame, California, United States
Investors Number:
10